Cyonanz Kit
Product Images NDC 65862-899

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cyonanz (NDC 65862-899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norethindroneethinyl Fig1)

A bar chart showing circulatory disease mortality rates per 100,000 woman-years categorized by age groups (15-24, 25-34, 35-44, 45+) and oral contraceptive use with smoking status. The chart compares ever-users (smokers and non-smokers) and controls (smokers and non-smokers), with mortality rates increasing notably in older age groups, especially among ever-users who smoke.*

FDA Label Image

Figure2 (Norethindroneethinyl Fig2)

A forest plot displaying effect estimates (OR/RR) with 95% confidence intervals from multiple studies evaluating contraceptive use. Studies are listed on the left with categories of 'Ever Use' and 'Current Use.' The horizontal axis shows effect estimates ranging from -1.5 to 2.0, centered at 1.0. Confidence intervals are depicted as horizontal lines with markers for point estimates.*

FDA Label Image

Figure3 (Norethindroneethinyl Fig3)

Cyonanz (Norethindrone and Ethinyl Estradiol) tablet kit showing a 28-day medication schedule. The kit includes white to off-white tablets for weeks 1 to 3 and green tablets for week 4. Each tablet contains 0.5 mg Norethindrone and 0.035 mg Ethinyl Estradiol, as labeled on the chart.*

FDA Label Image

Figure4 (Norethindroneethinyl Fig4)

An instructional illustration for Cyonanz kit (Norethindrone and Ethinyl Estradiol tablets, 0.5 mg / 0.035 mg) showing how to apply a day label sticker to the tablet blister pack. The diagram indicates selecting the correct day label (Mon-Sun) and placing it atop the pack containing circular tablet slots organized by weeks, with colored circles representing pill locations for different weeks.*

FDA Label Image

Figure5 (Norethindroneethinyl Fig5)

An instructional diagram for the Cyonanz kit (Norethindrone and Ethinyl Estradiol tablets) showing how to select and peel a day-of-week label (MON to SUN) and place it onto the pill card. The pill card displays rows of circular tablet slots labeled as white to off-white and green tablets, indicating their sequence in the kit.*

FDA Label Image

Figure6 (Norethindroneethinyl Fig6)

An instructional diagram showing a weekly dosage schedule for Cyonanz (Norethindrone and Ethinyl Estradiol Tablets USP) 0.5 mg/0.035 mg. The figure displays four rows representing four weeks, with days of the week labeled horizontally from Sunday to Saturday. The first three weeks have white to off-white circles indicating pills, while the fourth week shows green circles, guiding pill intake over a 28-day cycle.*

FDA Label Image

Package Label-principal Display Panel -0.5 mg/0.035 mg Pouch Label (Norethindroneethinyl Fig7)

An instructional diagram showing how to select and place a day-of-week label on a medication blister pack. The blister pack has four rows with circular tablet spaces; the first three rows are white to off-white circles, and the bottom row is green. A hand is shown peeling a strip with day labels (MON to SUN) to place on the pack. The image is labeled for Cyonanz (Norethindrone and Ethinyl Estradiol Tablets, USP) 0.5 mg/0.035 mg.*

FDA Label Image

Package Label-principal Display Panel -0.5 mg/0.035 mg Pouch Carton (Norethindroneethinyl Fig8)

Cyonanz (Norethindrone and Ethinyl Estradiol Tablets, USP) 0.5 mg/0.035 mg kit label from Aurobindo Pharma Limited. The label indicates a 28-day regimen, contains 1 pouch of 28 tablets, and includes basic product and manufacturer information along with a barcode.*

FDA Label Image

Norethindroneethinyl Fig9

Packaging label for Cyonanz, a kit containing Norethindrone and Ethinyl Estradiol tablets USP, 0.5 mg/0.035 mg dosage strength. The label shows a 28-day regimen with 6 pouches, each containing 28 tablets. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes storage instructions and a warning that the product is for prescription use only.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str)

Chemical structures of the active ingredients Norethindrone and Ethinyl Estradiol. The image depicts the molecular diagrams of both steroid compounds, showing their ring structures and functional groups, as labeled below each diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.